ClinicalTrials.gg
CompletedNCT06531616Updated Feb 17, 2025

Healthcare Professionals' Attitude Towards Clinical Research in the United Arab Emirates

An observational study in Behavior, Consumer, Research, Communication and Knowledge, Attitudes, Practice, sponsored by Abu Dhabi Health Services Company. Completed at 1 site in United Arab Emirates. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-17.

Primary conditionCommunicationRegistry: Consumer BehaviorReclassifiedWhy we changed it
Registry
Consumer Behavior — the first condition term the registry derived for this study.
ClinicalTrials.gg
Communication
Why
  1. Consumer Behavior is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Communication.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Abu Dhabi Health Services Company · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
597
Ages
18 Years and older
Sex
All
01

Study summary

Abu Dhabi Health Services Company (SEHA) is already in the process of providing support for research infrastructure, such as trained staff, medical facilities, funding, and training needs for its healthcare professionals (HCPs). An HCP's own interest in clinical research is an individualistic trait that SEHA wants to target and develop, complementary to its medical staff specialty, educational background, and willingness to learn.

The investigators' aim with this study is to understand the participants' perspective on challenges and barriers stopping them from conducting research and what supportive measures they have around them from the organization and the United Arab Emirates (UAE) that back their growth as research professionals at SEHA.

Read the detailed description

The investigators' aim with this study is to understand healthcare professionals' (HCPs) perspective on challenges and barriers stopping them from conducting research and what supportive measures they have around them from the organization and the United Arab Emirates (UAE) that back their growth as research professionals at Abu Dhabi Health Services Company -SEHA.

Investigators hypothesize that participants will give positive feedback on their interest in conducting clinical research but will outline barriers like lack of training opportunities, trained clinical operations staff, organizational support, protected time, etc. Moreover, they will also highlight the lack of data system training, participant accrual challenges, software interoperability issues, sponsor and contract research organization (CRO) issues, and lack of funding opportunities as major barriers to conducting research in the UAE.

02

Conditions studied

  • Behavior, Consumer
  • Research, Communication
  • Knowledge, Attitudes, Practice

Browse trials for

Keywords

  • Healthcare Professionals
  • Allied Health
  • Doctor
  • Nurses
  • Clinical Research
03

In context

Communication Reclassified

719 studies on the registry are indexed under Communication; 159 are open to participants now.

This study's enrollment of 597 is above the median of 104 across 132 observational studies indexed under Communication.

Browse Communication studies →

Lead sponsor

Abu Dhabi Health Services Company is the lead sponsor of 9 studies on the registry; 6 are open to participants now.

Compared within Communication, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Consumer Behavior. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population is comprised of SEHA healthcare employees.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Current SEHA Employee
  • Identify as a Healthcare Professional

Exclusion criteria

Exclusion Criteria:

  • Non-SEHA individuals
  • Non-Healthcare professionals
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
597 participants (actual)
Patient registry
No

Groups and cohorts

  • Healthcare professionals working at SEHA

    SEHA Healthcare employees (doctors, nurses, and allied health staff) will be approached through email to answer the study survey.

06

What researchers measure

Primary outcomes

  1. Understanding Knowledge and Attitudes of SEHA Healthcare professionals toward clinical research.

    A self-built survey was created to cover the different aspects of the United Arab Emirates (UAE) healthcare organizational practices and clinical research practices. The survey was pilot-tested on 6 volunteers not related to the Abu Dhabi Health Services Company (SEHA) for comprehension and ease of reading. The survey aims to understand participants' perspectives on challenges and barriers stopping them from conducting research and what supportive measures they have around them from the SEHA as an organization and the UAE that back their growth as medical research professionals. The data collected can help guide in bringing positive organizational changes to enhance clinical research at SEHA and in the UAE.

    Time frame: 3 months

07

Study locations

1 site
  • SEHA Head Quaters-Reserach Department
    Abu Dhabi, United Arab Emirates
08

References and documents

Publications

  • Al-Hajri A, Al-Khabori M, Rasool W. Productivity of Clinical Trials Conducted in the Gulf Cooperative Council Region. Sultan Qaboos Univ Med J. 2022 Nov;22(4):501-507. doi: 10.18295/squmj.11.2021.144. Epub 2022 Nov 7. PubMed 36407711 ↗
  • D'Arrietta LM, Vangaveti VN, Crowe MJ, Malau-Aduli BS. Rethinking Health Professionals' Motivation to Do Research: A Systematic Review. J Multidiscip Healthc. 2022 Jan 26;15:185-216. doi: 10.2147/JMDH.S337172. eCollection 2022. PubMed 35115782 ↗
  • Ito-Ihara T, Hong JH, Kim OJ, Sumi E, Kim SY, Tanaka S, Narita K, Hatta T, Choi EK, Choi KJ, Miyagawa T, Minami M, Murayama T, Yokode M. An international survey of physicians regarding clinical trials: a comparison between Kyoto University Hospital and Seoul National University Hospital. BMC Med Res Methodol. 2013 Oct 25;13:130. doi: 10.1186/1471-2288-13-130. PubMed 24156760 ↗
  • Silberman EK, Belitsky R, Bernstein CA, Cabaniss DL, Crisp-Han H, Dickstein LJ, Kaplan AS, Hilty DM, Nadelson CC, Scheiber SC. Recruiting researchers in psychiatry: the influence of residency vs. early motivation. Acad Psychiatry. 2012 Mar 1;36(2):85-90. doi: 10.1176/appi.ap.10010010. PubMed 22532195 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2024 to primary completion in Jul 2024, 2 months.

Of 51 non-industry observational studies under Communication, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 61. This study's 2 months is below that.

Counting every sponsor, half of 53 studies reached it within 25 months; a quarter within 9 and three quarters within 61.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 26, 2024
First posted
Aug 1, 2024
StartActual
May 15, 2024
Primary completionActual
Jul 31, 2024
CompletionActual
Dec 30, 2024
Last update
Feb 17, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 17, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06531616
Lead sponsor
Abu Dhabi Health Services Company
Responsible party
Alina Naeem (Assistant Manager Research Performance, Abu Dhabi Health Services Company) — Principal investigator
First posted
Aug 1, 2024
Start date
May 15, 2024
Primary completion
Jul 31, 2024
Completion
Dec 30, 2024
Last update
Feb 17, 2025

Study contacts

Mariam S Al Harbi, MD
study chair · Abu Dhabi Health Services Co. -SEHA
Erik BS Koornneef, PHD
study chair · Abu Dhabi Health Services Co. -SEHA

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion